Mainz Biomed: Amy Levin

Mainz Biomed appointed Amy Levin as vice president of regulatory affairs. Levin will be in charge of guiding implementation and regulatory, clinical trial, and quality initiatives related to in vitro diagnostics. Levin previously served as director of international regulatory affairs at Roche Molecular Diagnostics and has held other regulatory positions at multiple Bay Area biotechnology companies.